Rosiglitazone increases the concentration of large, buoyant but not small dense LDL in patients with type 2 diabetes and coronary artery disease, a 16 week randomised, double-blind, placebo-controlled study - UTU Research Portal - UTU Research Portal

Go to Header Go to Navigation Go to Content Go to Footer

Rosiglitazone increases the concentration of large, buoyant but not small dense LDL in patients with type 2 diabetes and coronary artery disease, a 16 week randomised, double-blind, placebo-controlled study

: Lautamaki R, Ronnemaa T, Airaksinen KEJ, Leino A, Hiekkanen H, Stewart M, Knuuti J, Nuutila P

Publisher: AMER DIABETES ASSOC

: 2005

Diabetes

: DIABETES

: DIABETES

: 54

: A123

: A123

: 1

: 0012-1797